CWGCX
Price
$68.12
Change
+$0.24 (+0.35%)
Updated
Jun 6 closing price
Net Assets
130.86B
MWEBX
Price
$40.24
Change
+$0.27 (+0.68%)
Updated
Jun 6 closing price
Net Assets
2.19B
Interact to see
Advertisement

CWGCX vs MWEBX

Header iconCWGCX vs MWEBX Comparison
Open Charts CWGCX vs MWEBXBanner chart's image
American Funds Capital World Gr&Inc C
Price$68.12
Change+$0.24 (+0.35%)
VolumeN/A
Net Assets130.86B
MFS Global Equity B
Price$40.24
Change+$0.27 (+0.68%)
VolumeN/A
Net Assets2.19B
CWGCX vs MWEBX Comparison Chart
Loading...
View a ticker or compare two or three
VS
CWGCX vs. MWEBX commentary
Jun 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CWGCX is a Buy and MWEBX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
CWGCX has more cash in the bank: 131B vs. MWEBX (2.19B). CWGCX pays higher dividends than MWEBX: CWGCX (0.87) vs MWEBX (0.00). CWGCX was incepted earlier than MWEBX: CWGCX (24 years) vs MWEBX (38 years). MWEBX (1.93) is less costly to investors than CWGCX (1.49). CWGCX is a more actively managed with annual turnover of: 27.00 vs. MWEBX (8.00). CWGCX has a lower initial minimum investment than MWEBX: CWGCX (250) vs MWEBX (1000). CWGCX annual gain was more profitable for investors over the last year : 5.53 vs. MWEBX (-7.48). CWGCX return over 5 years is better than : 42.30 vs. MWEBX (-4.33).
CWGCXMWEBXCWGCX / MWEBX
Total Expense Ratio1.491.9078%
Annual Report Gross Expense Ratio1.491.9377%
Fund Existence24 years38 years-
Gain YTD8.7115.881148%
Front LoadN/AN/A-
Min. Initial Investment250100025%
Min. Initial Investment IRAN/AN/A-
Net Assets131B2.19B5,982%
Annual Yield % from dividends0.870.00-
Returns for 1 year5.53-7.48-74%
Returns for 3 years26.86-12.58-214%
Returns for 5 years42.30-4.33-976%
Returns for 10 years49.3117.51282%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VERV6.200.47
+8.12%
Verve Therapeutics
PIII6.620.14
+2.24%
P3 Health Partners Inc
VSAT9.210.09
+0.99%
ViaSat
NLY19.060.18
+0.95%
Annaly Capital Management
RELI1.47-0.04
-2.65%
Reliance Global Group Inc.